U.S. flag An official website of the United States government

On Oct. 1, 2024, the FDA began implementing a reorganization impacting many parts of the agency. We are in the process of updating FDA.gov content to reflect these changes.

  1. Home
  2. Vaccines, Blood & Biologics
  3. Cellular & Gene Therapy Products
  4. REGENECYTE
  1. Cellular & Gene Therapy Products

STN: 125764
Proper Name: HPC, Cord Blood
Tradename: REGENECYTE
Manufacturer: StemCyte, Inc.
Indication:

  • For use in unrelated donor hematopoietic progenitor cell transplantation procedures in conjunction with an appropriate preparative regimen for hematopoietic and immunologic reconstitution in patients with disorders affecting the hematopoietic system that are inherited, acquired, or result from myeloablative treatment.

Product Information

Supporting Documents

Back to Top